RFK Jr. Faces Congress Over Sweeping Health Agency Overhaul
Washington, D.C. – May 13, 2025 – U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is set to testify before the U.S. Senate’s Health, Education, Labor, and Pensions Committee on May 14, 2025, to address his controversial overhaul of federal health agencies. The hearing, announced by the committee on May 2, comes amid growing scrutiny of Kennedy’s “Make America Healthy Again” (MAHA) initiative, which has sparked alarm among public health experts, advocacy groups, and lawmakers over its sweeping changes to the Department of Health and Human Services (HHS) and its subordinate agencies, including the FDA, CDC, and NIH.
The Overhaul: A Radical Restructuring
Kennedy, appointed by President Donald Trump, has moved swiftly to reshape HHS since taking office. In late March, he announced a consolidation of 28 HHS divisions into 15 offices, including a new Administration for a Healthy America, aimed at addressing chronic diseases and nutrition. This restructuring, described as a “confusing reorganization” by critics, has led to significant layoffs, with reports of 10,000 job cuts across HHS, including over 2,000 at the NIH alone. Key minority health offices, critical for reducing health disparities, have been gutted, with many staff laid off, prompting backlash from advocates and Democratic-led states.
Kennedy’s agenda also includes controversial policy shifts:
- Vaccine Policy: Kennedy, a longtime vaccine skeptic, has mandated placebo-controlled trials for new vaccines, a move experts warn could delay approvals and undermine public confidence in immunizations. His response to a measles outbreak—focusing on unproven treatments like vitamins instead of promoting the 97% effective MMR vaccine—has drawn intense criticism.
- Autism Initiatives: Kennedy’s plan to create a national autism database using Medicare, Medicaid, and private medical records has raised privacy concerns and angered the autism community, who accuse him of perpetuating harmful stereotypes by framing autism as an “epidemic” caused by environmental toxins.
- Food and Nutrition: Kennedy has pushed for banning nine petroleum-based synthetic food dyes by 2026, ending fluoridation due to alleged IQ impacts, and removing soda from the food stamps program, earning some bipartisan support but also skepticism about feasibility.
- Budget Cuts: A leaked White House memo revealed plans to slash a third of the federal health budget, eliminate dozens of programs, and withhold NIH funding from universities not aligning with administration policies, raising fears of crippled public health infrastructure.
These changes have triggered a lawsuit from 19 Democratic-led states and the District of Columbia, alleging that Kennedy’s restructuring violates congressional mandates by halting legally required functions like food safety inspections and infectious disease prevention.
Congressional Scrutiny: What to Expect
Kennedy’s testimony before the Senate health committee, chaired by Republican Senator Bill Cassidy, follows months of mounting pressure. Cassidy called for the hearing in early April amid reports of low morale at HHS and resignations of key officials, including Peter Marks, the FDA’s top vaccine regulator. The committee is expected to press Kennedy on:
- Vaccine Safety and Public Health: Senators will likely challenge Kennedy’s vaccine policies, particularly his misleading claims about “fetal debris” in measles shots and his reluctance to endorse vaccination during the worst measles outbreak in 25 years, with over 1,000 cases reported by May 9, 2025.
- Autism Registry Concerns: Advocacy groups, including autistic individuals like Seth Taylor, have demanded Kennedy retract his autism registry plan, citing privacy violations and stigmatization. Senators may question the scientific basis and ethical implications of the initiative.
- Budget and Job Cuts: The proposed elimination of 10,000 HHS jobs and cuts to minority health offices have alarmed lawmakers, especially Democrats like Rep. Rosa DeLauro, who called Kennedy’s actions a “terrifying” assault on America’s health system. The impact on the Indian Health Service, highlighted by a bipartisan Senate letter, will also be a focal point.
- Industry and State Cooperation: Kennedy’s food agenda, such as dye bans, requires industry and state buy-in, which has been slow to materialize. Senators may probe how Kennedy plans to navigate these challenges without congressional approval, which could delay major policy changes.
Mixed Reactions: Support and Alarm
Kennedy’s MAHA movement has resonated with some, particularly Trump’s base and wellness advocates, who see his focus on nutrition and chronic disease as a bold departure from a “sick care” system. Posts on X highlight his team—Jay Bhattacharya (NIH), Marty Makary (FDA), and Mehmet Oz (CMS)—as a united front to dismantle corrupt health structures. His food dye ban and anti-fluoridation stance have also gained traction among MAHA supporters.
However, public health experts and advocacy groups are sounding alarms. Paul Offit, a vaccine expert, called Kennedy a “dangerous man” intent on tearing down vaccine infrastructure. The autism community, led by figures like Ari Ne’eman, has condemned Kennedy’s remarks as fearmongering, while 19 states’ lawsuit underscores fears that his overhaul paralyzes critical health functions. On X, critics like Rep. Jasmine Crockett have labeled the changes “reckless,” warning of weakened pandemic preparedness and healthcare access for vulnerable populations.
Political Context and Implications
Kennedy’s expanded influence, celebrated by Trump aides for securing the popular vote in 2024, has positioned him as a key figure in the administration. His ability to rally MAHA loyalists is seen as critical for GOP midterm success, but his overreach into areas like agriculture and education has ruffled feathers among other agencies. The hearing could shape public and congressional support for his agenda, especially as budget cuts face resistance from both parties.
Looking Ahead
As Kennedy prepares to face Congress, the stakes are high. His testimony will test his ability to defend a radical vision that has both inspired and alienated stakeholders. While his supporters view him as a reformer taking on entrenched interests—Big Pharma, Big Food, and Big Insurance—critics argue his policies risk dismantling decades of public health progress. The outcome of the hearing could influence the trajectory of HHS reforms and Kennedy’s tenure as one of the most polarizing health secretaries in U.S. history.
For more details on Kennedy’s testimony, tune into the Senate Health Committee’s live session on May 14, 2025, or follow updates from trusted sources like NPR, Reuters, or The Washington Post.
Note: Claims about Kennedy’s policies, including those from X posts, are treated as inconclusive unless verified by official sources. This article draws on web reports and X sentiment to provide a balanced overview.